CD44 and Obesity: These results imply that CD44 is a key factor to cause insulin resistance via adipose tissue inflammation, and its blocking might be a potential therapeutic strategy for the treatment of T2D by breaking the links between obesity-induced insulin resistance and adipose tissue inflammation.